# Filing Detail

Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001104659-25-047011
Filing Date
2025-05-12
Accepted
2025-05-12 07:12:30
Documents
30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-4/A | tm256615-13_s4a.htm | S-4/A | 8386766
2 | EXHIBIT 5.1 | tm256615d15_ex5-1.htm | EX-5.1 | 22090
3 | EXHIBIT 8.1 | tm256615d15_ex8-1.htm | EX-8.1 | 16578
4 | EXHIBIT 23.1 | tm256615d15_ex23-1.htm | EX-23.1 | 2025
5 | EXHIBIT 23.2 | tm256615d15_ex23-2.htm | EX-23.2 | 1988
6 | EXHIBIT 23.4 | tm256615d15_ex23-4.htm | EX-23.4 | 5300
7 | EX-FILING FEES | tm256615d15_ex-filingfees.htm | EX-FILING FEES | 42401
8 | GRAPHIC | bc_inhibitors-4c.jpg | GRAPHIC | 52077
9 | GRAPHIC | bc_paidvsnetincome-4c.jpg | GRAPHIC | 34273
10 | GRAPHIC | bc_paidvstsr-4c.jpg | GRAPHIC | 34272
11 | GRAPHIC | fc_chemotherapy-4clr.jpg | GRAPHIC | 96809
12 | GRAPHIC | fc_cr002adc-4c.jpg | GRAPHIC | 85532
13 | GRAPHIC | ft_lucidcapnewyork-bw.jpg | GRAPHIC | 6723
14 | GRAPHIC | lc_cooperative-4c.jpg | GRAPHIC | 64616
15 | GRAPHIC | lc_nsclc-4clr.jpg | GRAPHIC | 78916
16 | GRAPHIC | lg_crescent-4clr.jpg | GRAPHIC | 13366
17 | GRAPHIC | lg_glycomimetics-4c.jpg | GRAPHIC | 33723
18 | GRAPHIC | lg_lucidcapital-bwlr.jpg | GRAPHIC | 7806
19 | GRAPHIC | lg_walkers-bwlr.jpg | GRAPHIC | 4795
20 | GRAPHIC | ph_antivegf-4c.jpg | GRAPHIC | 83797
21 | GRAPHIC | ph_cr001-4clr.jpg | GRAPHIC | 108813
22 | GRAPHIC | ph_vegf-4clr.jpg | GRAPHIC | 44251
23 | GRAPHIC | px_glycoproxy1pg01-bw.jpg | GRAPHIC | 285436
24 | GRAPHIC | px_glycoproxy1pg02-bw.jpg | GRAPHIC | 234594
25 | GRAPHIC | sg_lucidcapitalmarkets-bw.jpg | GRAPHIC | 6380
26 | GRAPHIC | tb_clinicaldevelop-4c.jpg | GRAPHIC | 62088
27 | GRAPHIC | tb_pfs-4c.jpg | GRAPHIC | 26172
28 | GRAPHIC | tm256615d15_ex8-1img01.jpg | GRAPHIC | 3476
29 | GRAPHIC | tm256615d15_ex23-4img001.jpg | GRAPHIC | 3268
30 | GRAPHIC | tm256615d15_ex5-1img001.jpg | GRAPHIC | 2558
| Complete submission text file | 0001104659-25-047011.txt |  | 10329907

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-285035 | Film No.: 25932569
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)